Expression profiles of long noncoding RNAs in lung adenocarcinoma
Authors Zhao B, Xu H, Ai X, Adalat Y, Tong Y, Zhang J, Yang S
Received 8 March 2018
Accepted for publication 13 May 2018
Published 6 September 2018 Volume 2018:11 Pages 5383—5390
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Leo Jen-Liang Su
Bing Zhao,1 Hang Xu,2 Xiaoye Ai,1 Yasheng Adalat,1 Ying Tong,1 Jiazhennan Zhang,1 Shune Yang3
1Department of Day Oncology, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China; 2Intensive Care Unit, The Sixth Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 3Department of Breast Cancer and Lymphoma, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China
Purpose: This study aimed to analyze expression profiles of long noncoding RNAs (lncRNAs) in lung adenocarcinoma.
Methods: lncRNA microarray technology was employed to detect lncRNA profiles of 3 pairs of lung adenocarcinoma tissues and adjacent tissues.
Results: We found 134 upregulated lncRNAs and 460 downregulated lncRNAs in lung adenocarcinoma tissues compared to adjacent tissues. Among them, LINC00152, LINC00691, and LINC00578 showed the most significant changes of upregulation, while LINC00668, LINC00710, and LINC00607 showed the most significant changes of downregulation. Fluorescent quantitative polymerase chain reaction (PCR) analysis of tissue samples from an additional 90 patients with lung adenocarcinoma showed significantly increased levels of LINC00152, LINC00691, and LINC00578 and decreased levels of LINC00668, LINC00710, and LINC00607 in lung adenocarcinoma tissues. In addition, LINC00578 was closely associated with the existence of metastasis of lung adenocarcinoma, but the other 5 lncRNAs showed no significant correlation with clinicopathologic characteristics such as age, gender, tumor stage, and the existence of metastasis. Further follow-up study showed that LINC00578 expression was closely associated with the survival of patients with lung adenocarcinoma.
Conclusion: We revealed the expression profiles of lncRNAs in lung adenocarcinoma and identified LINC00578 as a promising biomarker and therapeutic target for lung adenocarcinoma.
Keywords: long noncoding RNA, microarray, lung adenocarcinoma, survival
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]